Market Research

Dog Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration (Injectables, Oral), By Duration Of Immunity, By Component (Combined Vaccines, Mono Vaccines), By Region, And Segment Forecasts, 2025 - 2

Best Price Guarantee Length Publisher Published Date SKU
from $5,950 150 Pages Grand View Research December, 2024 GV19482424
Best Price Guarantee
Price from $5,950
Length 150 Pages
Publisher Grand View Research
Published Date December, 2024
SKU GV19482424

Dog Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration (Injectables, Oral), By Duration Of Immunity, By Component (Combined Vaccines, Mono Vaccines), By Region, And Segment Forecasts, 2025 - 2030


Dog Vaccine Market Growth & Trends

The global dog vaccine market size is anticipated to reach USD 2.88 billion by 2030 and display a CAGR of 6.45% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to the increasing trend of pet humanization, pet ownership among millennials, and rising consciousness regarding preventive healthcare. According to Boehringer Ingelheim International GmbH, 35% of millennials and 32% of baby boomers own a pet. In addition, the rise in pet spending and insurance is also expected to add to the growth of this market. According to an article published by WorldAnimalFoundation.org in February 2023, dog owners spent approximately USD 570 more than cat owners.

Moreover, the increasing pet population, rising income levels in emerging markets of Asia-Pacific, such as China and India, and consequent changes in the lifestyle of people are expected to impact the growth of the dog vaccine industry significantly. For instance, according to an article published by the Economic Times in July 2023, the per capita income in India is expected to increase by 1.6 times to reach USD 4000 by 2030.

Dog Vaccine Market Report Highlights
  • Based on vaccine type, the modified/attenuated live vaccine segment accounted for the largest revenue share of 52.03% in 2024, as they help prevent disease and provide long-term immunity.
  • Based on disease type, the canine rabies segment is expected to grow at the fastest CAGR of 7.3% over the forecast period due to the high prevalence of this disease and its zoonotic potential.
  • Based on route of administration, the oral vaccine segment is expected to grow at the fastest CAGR from 2025 to 2030.
  • Based on duration of immunity, the 1-year segment dominated the market with a share of 51.2% in 2024 owing to their convenience.
  • Based on component, the combined vaccines segment accounted for the largest market share of 65%. It is expected to grow at the fastest CAGR over the forecast period due to its ability to protect against more than one disease.
  • North America dominated with a share of 38% in 2024, owing to the presence of major players and increasing awareness regarding preventive healthcare for pets. On the other hand, the Asia Pacific dogs vaccine market is expected to grow at the fastest CAGR over the forecast period.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Duration of Immunity
1.2.2. Vaccine Type
1.2.3. Disease type
1.2.4. Route of Administration
1.2.5. Distribution Channel
1.2.6. Regional Scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Dogs Vaccines Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising pet ownership and pet humanization
3.2.1.2. Increasing concerns over zoonotic diseases
3.2.1.3. Technological advancements
3.2.1.4. Initiatives by market participants
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of adoption of immunization in endemic cuntries
3.3. Dogs Vaccines Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.2.7. Estimated Dog Population by key Species, key Country, 2018-2024
3.4. Regulatory Framework
3.5. Pricing Analysis
3.6. COVID-19 impact Analysis
Chapter 4. Dogs Vaccines Market: Durastion of Immunity Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Dogs Vaccines Market: Duration of Immunity Movement Analysis
4.3. Dogs Vaccines Market by Duration of Immunity Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. 1 year
4.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.6. 3 years
4.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5. Dogs Vaccines Market: Vaccine Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Dogs Vaccines Market: Vaccine Type Movement Analysis
5.3. Dogs Vaccines Market by Vaccine Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Modified/ Attenuated Live
5.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6. Inactivated (Killed)
5.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7. Other Vaccines
5.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6. Dogs Vaccines Market: Disease Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Dogs Vaccines Market: Disease type Movement Analysis
6.3. Dogs Vaccines Market by Disease type Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Canine Distemper
6.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6. Canine Infectious Respiratory Disease Complex (CIRDC)
6.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.7. Canine Parvovirosis/ Parvovirus Disease
6.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.8. Canine Leptospirosis
6.8.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.9. Canine Lyme Disease
6.9.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.10. Infectious Canine Hepatitis
6.10.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.11. Canine Rabies
6.11.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.12. Other Diseases
6.12.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7. Dogs Vaccines Market: Route of Administration Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Dogs Vaccines Market: Route of Administration Movement Analysis
7.3. Dogs Vaccines Market by Route of Administration Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Injectable
7.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6. Intranasal
7.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7. Oral
7.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8. Dogs Vaccines Market: Component Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Dogs Vaccines Market: Component Movement Analysis
8.3. Dogs Vaccines Market by Component Outlook (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. Combined Vaccines
8.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6. Mono Vaccines
8.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9. Dogs Vaccines Market: Distribution Channel Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Dogs Vaccines Market: Distribution Channel Movement Analysis
9.3. Dogs Vaccines Market by Distribution Channel Outlook (USD Million)
9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
9.5. Retail
9.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.6. E-Commerce
9.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.7. Hospital/Clinic Pharmacies
9.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 10. Dogs Vaccines Market: Regional Estimates & Trend Analysis
10.1. Regional Dashboard
10.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
10.3. North America
10.3.1. U.S.
10.3.1.1. Key country dynamics
10.3.1.2. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
10.3.2. Canada
10.3.2.1. Key country dynamics
10.3.2.2. Canada market estimates and forecasts 2018 to 2030 (USD Million)
10.3.3. Mexico
10.3.3.1. Key country dynamics
10.3.3.2. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
10.4. Europe
10.4.1. UK
10.4.1.1. Key country dynamics
10.4.1.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
10.4.2. Germany
10.4.2.1. Key country dynamics
10.4.2.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
10.4.3. France
10.4.3.1. Key country dynamics
10.4.3.2. France market estimates and forecasts 2018 to 2030 (USD Million)
10.4.4. Italy
10.4.4.1. Key country dynamics
10.4.4.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
10.4.5. Spain
10.4.5.1. Key country dynamics
10.4.5.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
10.4.6. Sweden
10.4.6.1. Key country dynamics
10.4.6.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
10.4.7. Denmark
10.4.7.1. Key country dynamics
10.4.7.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
10.4.8. Norway
10.4.8.1. Key country dynamics
10.4.8.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
10.4.9. Rest of Europe
10.4.9.1. Key country dynamics
10.4.9.2. Rest of Europe market estimates and forecasts 2018 to 2030 (USD Million)
10.5. Asia Pacific
10.5.1. Japan
10.5.1.1. Key country dynamics
10.5.1.2. Japan market estimates and forecasts 2018 to 2030 (USD Million)
10.5.2. China
10.5.2.1. Key country dynamics
10.5.2.2. China market estimates and forecasts 2018 to 2030 (USD Million)
10.5.3. India
10.5.3.1. Key country dynamics
10.5.3.2. India market estimates and forecasts 2018 to 2030 (USD Million)
10.5.4. Australia
10.5.4.1. Key country dynamics
10.5.4.2. Australia market estimates and forecasts 2018 to 2030 (USD Million)
10.5.5. South Korea
10.5.5.1. Key country dynamics
10.5.5.2. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
10.5.6. Thailand
10.5.6.1. Key country dynamics
10.5.6.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
10.5.7. Rest of Asia-Pacific
10.5.7.1. Key country dynamics
10.5.7.2. Rest of Asia-Pacific market estimates and forecasts 2018 to 2030 (USD Million)
10.6. Latin America
10.6.1. Brazil
10.6.1.1. Key country dynamics
10.6.1.2. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
10.6.2. Argentina
10.6.2.1. Key country dynamics
10.6.2.2. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
10.6.3. Rest of LA
10.6.3.1. Key country dynamics
10.6.3.2. Rest of LA market estimates and forecasts 2018 to 2030 (USD Million)
10.7. MEA
10.7.1. South Africa
10.7.1.1. Key country dynamics
10.7.1.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
10.7.2. Saudi Arabia
10.7.2.1. Key country dynamics
10.7.2.2. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
10.7.3. UAE
10.7.3.1. Key country dynamics
10.7.3.2. UAE market estimates and forecasts 2018 to 2030 (USD Million)
10.7.4. Kuwait
10.7.4.1. Key country dynamics
10.7.4.2. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
10.7.5. Rest of MEA
10.7.5.1. Key country dynamics
10.7.5.2. Rest of MEA market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 11. Competitive Landscape
11.1. Company Categorization
11.2. Recent Developments & Impact Analysis by Key Market Participants
11.3. Company Market Share Analysis, 2024
11.4. Company overview
11.4.1. Boehringer Ingelheim International GmbH
11.4.1.1. Company Overview
11.4.1.2. Financial performance
11.4.1.3. Product benchmarking
11.4.1.4. Strategic initiatives
11.4.2. Zoetis Services LLC
11.4.2.1. Company Overview
11.4.2.2. Financial performance
11.4.2.3. Product benchmarking
11.4.2.4. Strategic initiatives
11.4.3. Hester Biosciences Limited
11.4.3.1. Company Overview
11.4.3.2. Financial performance
11.4.3.3. Product benchmarking
11.4.3.4. Strategic initiatives
11.4.4. Merck & Co., Inc.
11.4.4.1. Company Overview
11.4.4.2. Financial performance
11.4.4.3. Product benchmarking
11.4.4.4. Strategic initiatives
11.4.5. Virbac
11.4.5.1. Company Overview
11.4.5.2. Financial performance
11.4.5.3. Product benchmarking
11.4.5.4. Strategic initiatives
11.4.6. Bioveta a.s
11.4.6.1. Company Overview
11.4.6.2. Financial performance
11.4.6.3. Product benchmarking
11.4.6.4. Strategic initiatives
11.4.7. Elanco
11.4.7.1. Company Overview
11.4.7.2. Financial performance
11.4.7.3. Product benchmarking
11.4.7.4. Strategic initiatives
11.4.8. Brilliant Bio Pharma
11.4.8.1. Company Overview
11.4.8.2. Financial performance
11.4.8.3. Product benchmarking
11.4.8.4. Strategic initiatives
11.4.9. Heska Corporation
11.4.9.1. Company Overview
11.4.9.2. Financial performance
11.4.9.3. Product benchmarking
11.4.9.4. Strategic initiatives
11.4.10. Zendal Group
11.4.10.1. Company Overview
11.4.10.2. Financial performance
11.4.10.3. Product benchmarking
11.4.10.4. Strategic initiatives

$5,950
$6,950
$8,950

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings